Federal Register #B-90-2026

Proposed Pharmaceutical Manufacturing Activity by Patheon Pharmaceuticals in FTZ 46 (Cincinnati, OH)

This opportunity concerns a proposed pharmaceutical manufacturing activity in a designated Foreign-Trade Zone (FTZ): - Government buyer: Department of Commerce, Foreign-Trade Zones Board - OEM highlighted: Patheon Pharmaceuticals Inc. - Activity location: FTZ 46, Cincinnati, Ohio - Products involved: - Finished vibegron tablets (pharmaceutical product) - Vibegron (active pharmaceutical ingredient, Beta-3 adrenergic receptor) - Patheon Pharmaceuticals Inc. seeks approval to use foreign-status vibegron to manufacture finished tablets at its facility - No specific purchase quantities or part numbers are provided - The notification is for public comment and outlines the regulatory context for the proposed production - No additional vendors or service providers are mentioned

Description

The Department of Commerce's Foreign-Trade Zones Board has received a notification from Patheon Pharmaceuticals Inc. regarding a proposed production activity within FTZ 46 in Cincinnati, Ohio. The activity involves the manufacturing of pharmaceutical products, specifically finished vibegron tablets. The proposed foreign-status material is vibegron, an active pharmaceutical ingredient. Public comments are invited until September 8, 2026.

View original listing